Existing investor SoftBank Ventures Asia helped the online investment platform developer close a round that will fund its growth in Indonesia.

Lilly Asia Ventures has led a $23.2m round for the digital diagnostics technology developer, investing alongside new and existing backers.

Sanofi and Mass General Brigham contributed to a round that pushed the immunotherapy developer's total funding to nearly $60m.

The McKesson-backed software provider secured $44m in series D funding alongside the acquisition of healthcare software developer Mavens.

Cambrian Biopharma returned to back the immunotherapy developer's series B round, following its series A three months ago.

ADM Ventures, GV and Barclays helped the microbe-based protein developer close a round that will support research and development.

Rich Products Ventures has helped the meal delivery service secure $10.3m to hike its overall funding to $26m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

GV and Nextech contributed to a series B round that boosted the affordable pharmaceutical developer's overall funding to $750m.

The brain disease treatment developer was founded in 2019 on the back of more than a decade’s collaborative research from MIT and Harvard.